M&A, Pharma

M&A news: Perrigo buys Omega Pharma for $4.5 billion

Posted on 07 November 2014

Tags: , ,

In today's m&a news, Perrigo Company announced today that it will acquire Belgium-based Omega Pharma for $4.5 billion.

Perrigo develops, manufactures and distributes over-the-counter and generic prescription drugs, nutritional products and active pharmaceutical ingredients.

Omega is an over-the-counter healthcare company that operates in 35 countries across Europe and certain emerging markets.

The deal is a mix of cash and equity valued at $4.5 billion.

Perrigo will purchase Omega’s equity for €2.48 billion and take on €1.1 billion in debt.

Twenty-five percent of the equity purchase price will be funded by Perrigo stock, about 5 million shares, going directly to Coucke, and 75 percent will be funded via a combination of cash and debt.

J.P. Morgan Chase Bank, N.A. and Barclays have provided Perrigo with a €1.75 billion bridge.

The transaction has been unanimously approved by both companies’ boards and is expected to close in the first quarter of 2015.

For further deal information visit Current Agreements (subscription required)


Report:   Top 50 Big Pharma Partnering and M&A Deal Trends

Report:   Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply